TOXIN PEPTIDE THERAPEUTIC AGENTS

Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NGUYEN, HUNG Q, MARTIN, FRANCIS H, SULLIVAN, JOHN K, GEGG, COLIN V., JR, MCGIVERN, JOSEPH G, ARORA KHARE, TARUNA, MIRANDA, LESLIE P, WALKER, KENNETH W, ADLER, BEVERLY S, HU, SHAW-FEN SYLVIA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Disclosed is a composition of matter comprising an OSK1 peptide analog, a nd in some embodiments, a pharmaceutically acceptable salt thereof. A pharma ceutical composition comprises the composition and a pharmaceutically accept able carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising t he expression vector. Methods of treating an autoimmune disorder and of prev enting or mitigating a relapse of a symptom of multiple sclerosis are also d isclosed.